TaiMed Biologics (4147) — Working Capital to Net Assets Ratio
TaiMed Biologics (4147) has a Working Capital to Net Assets ratio of 78.7% as of March 2026. Working capital of NT$2.99 Billion (current assets of NT$3.18 Billion minus current liabilities of NT$188.95 Million) is measured against net assets of NT$3.80 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of TaiMed Biologics to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
TaiMed Biologics Working Capital to Net Assets (2015–2025)
This chart shows how TaiMed Biologics's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 78.7%, reflecting working capital of NT$2.99 Billion against net assets of NT$3.80 Billion TWD. For the complete balance sheet picture, see 4147 asset base.
Annual Working Capital to Net Assets for TaiMed Biologics (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for TaiMed Biologics from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check TaiMed Biologics liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 79.6% | NT$3.07 Billion | NT$3.86 Billion | NT$3.32 Billion | NT$253.51 Million | ▼ -1.5 pp |
| 2024 | 81.0% | NT$3.26 Billion | NT$4.02 Billion | NT$3.39 Billion | NT$134.76 Million | ▲ +11.2 pp |
| 2023 | 69.8% | NT$1.79 Billion | NT$2.57 Billion | NT$2.15 Billion | NT$361.17 Million | ▲ +2.2 pp |
| 2022 | 67.6% | NT$1.84 Billion | NT$2.71 Billion | NT$2.16 Billion | NT$329.86 Million | ▼ -4.1 pp |
| 2021 | 71.7% | NT$2.11 Billion | NT$2.94 Billion | NT$2.33 Billion | NT$225.08 Million | ▲ +3.9 pp |
| 2020 | 67.8% | NT$2.32 Billion | NT$3.42 Billion | NT$2.78 Billion | NT$461.52 Million | ▲ +11.2 pp |
| 2019 | 56.6% | NT$2.03 Billion | NT$3.59 Billion | NT$2.46 Billion | NT$428.11 Million | ▲ +0.6 pp |
| 2018 | 55.9% | NT$2.28 Billion | NT$4.08 Billion | NT$2.52 Billion | NT$235.94 Million | ▼ -27.0 pp |
| 2017 | 82.9% | NT$3.56 Billion | NT$4.29 Billion | NT$3.66 Billion | NT$98.59 Million | ▼ -9.8 pp |
| 2016 | 92.8% | NT$4.37 Billion | NT$4.71 Billion | NT$4.43 Billion | NT$60.17 Million | ▼ -0.1 pp |
| 2015 | 92.8% | NT$4.55 Billion | NT$4.90 Billion | NT$4.58 Billion | NT$26.63 Million | — |